Allergan Aesthetics and BOTOX® Cosmetic (onabotulinumtoxinA) Put Real Stories at the Forefront in New Campaign – PR Newswire
Allergan Aesthetics launches new BOTOX® Cosmetic campaign featuring authentic patient stories and real user experiences.
Allergan Aesthetics launches new BOTOX® Cosmetic campaign featuring authentic patient stories and real user experiences.
Eli Lilly’s oral GLP-1 drug orforglipron could transform the market by offering a pill alternative to weekly injections.
Global exosome therapy market projected to reach $309.60 million as regenerative medicine field expands with promising treatments.
A surge in demand combined with manufacturing issues has created widespread shortages of menopause hormone therapy prescriptions.
New Cambridge research examines how menopause and HRT affect memory, concentration, and emotional well-being in women.
New research suggests GLP-1 weight loss medications may provide mental health benefits beyond their metabolic effects.
New data shows type 1 diabetes patients using GLP-1 drugs experience improved heart and kidney health outcomes.
HHS removes FDA warnings on hormone replacement therapy, calling them misleading and urging more balanced menopause treatment guidance.
New peptide therapy boosts survival in sepsis by correcting immune system genes in the spleen and lungs, researchers report.
Peptides have become the latest luxury wellness trend, though experts warn many products lack regulatory oversight and clinical evidence.